Synapticure CEO Sandra Abrevaya (second from left) speaks at the 2024 Health Evolution Connect conference (Photo: Wilde Company)

Ex­clu­sive: Synap­ti­c­ure rais­es $25M for its ap­proach to vir­tu­al neu­rode­gen­er­a­tive dis­ease care

Synap­ti­c­ure, a start­up build­ing dig­i­tal health tools for peo­ple with neu­rode­gen­er­a­tive con­di­tions and their care­givers, has raised a new round of fund­ing to bring its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.